These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)]. Rizzari C; Santamaria M; Galli MA; Jankovic M; Uderzo C Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847 [TBL] [Abstract][Full Text] [Related]
28. [Rubomycin in the therapy of acute leukemias]. Khvatova NV Antibiotiki; 1970 Dec; 15(12):1108-11. PubMed ID: 5278101 [No Abstract] [Full Text] [Related]
29. Anthracycline-induced cardiomyopathy in children: a report of six cases. Dearth J; Osborn R; Wilson E; Kelly D; Mantle J; Rogers E; Malluh A; Crist W Med Pediatr Oncol; 1984; 12(1):54-8. PubMed ID: 6583470 [TBL] [Abstract][Full Text] [Related]
30. Correction to "Congestive heart failure after treatment for Wilms' tumor". Green DM; Grigoriev YA; Nan B; Takashima JR; Norkool PA; D'Angio GJ; Breslow NE J Clin Oncol; 2003 Jun; 21(12):2447-8. PubMed ID: 12805354 [No Abstract] [Full Text] [Related]
31. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial. Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002 [TBL] [Abstract][Full Text] [Related]
32. The present of situation in treatment and prognosis of childhood acute lymphocytic leukemia with an outlook for the future. Simone JV Haematologica; 1982 Jun; 67(3):329-34. PubMed ID: 6814989 [No Abstract] [Full Text] [Related]
33. [Cardiotoxicity in anthracycline chemotherapy: significance of infusion durations. Analysis of a Cochrane review]. Appel JM; Rybjerg M; Nielsen DL Ugeskr Laeger; 2007 Sep; 169(37):3105-7. PubMed ID: 17877960 [No Abstract] [Full Text] [Related]
34. Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents. Chen C; Heusch A; Donner B; Janssen G; Göbel U; Schmidt KG Klin Padiatr; 2009; 221(3):162-6. PubMed ID: 19437364 [TBL] [Abstract][Full Text] [Related]
35. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia. Warrell RP; Arlin ZA; Kempin SJ; Young CW Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022 [TBL] [Abstract][Full Text] [Related]
36. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen. Poplack DG; Reaman GH; Wesley R Cancer Treat Rep; 1981; 65 Suppl 4():93-6. PubMed ID: 6955015 [TBL] [Abstract][Full Text] [Related]
37. [Cardiac complications observed during treatment with rubidomycin]. Macrez C; Marneffe-Lebrequier H; Ripault J; Clauvel JP; Jacquillat C; Weil M Pathol Biol; 1967 Oct; 15(19):949-53. PubMed ID: 4869773 [No Abstract] [Full Text] [Related]
38. Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study. Bickers J; Benjamin R; Wilson H; Eyre H; Hewlett J; McCredie K Cancer Treat Rep; 1981; 65(5-6):427-30. PubMed ID: 6940659 [TBL] [Abstract][Full Text] [Related]
39. [Can the toxicity of rubidomycin in the treatment of acute leukemia in children be limited?]. Wyszkowski J; Cyklis R; Armata J; Zajaczkowski J Przegl Lek; 1971; 27(4):335-8. PubMed ID: 5283077 [No Abstract] [Full Text] [Related]
40. [Heart failure in a subject treated with anthracyclines in childhood: myocardial dysfunction is not always the only reason of it]. Iarussi D; Martino V; Iacono C; Indolfi P; Muto R; Calabrò R Ital Heart J Suppl; 2004 Apr; 5(4):294-7. PubMed ID: 15346697 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]